Proteomic profiling in plasma cell disorders: a feasibility study

Leuk Lymphoma. 2017 Jul;58(7):1757-1759. doi: 10.1080/10428194.2016.1258699. Epub 2016 Dec 2.

Sham Mailankody^{1

2}, Sean M Devlin³, Neha Korde^{1

2}, Nikoletta Lendvai^{1

2}, Alexander Lesokhin^{1

2}, Heather Landau^{2

4}, Hani Hassoun^{1

2}, Andrea Ballagi⁵, Daniel Ekman⁵, David J Chung^{2

4}, Minal Patel⁶, Guenther Koehne^{2

4}, Sergio Giralt^{2

4}, Ola Landgren^{1

2}

¹ a Department of Medicine, Myeloma Service , Memorial Sloan Kettering Cancer Center , New York , NY , USA.
² b Department of Medicine , Weill Cornell Medical College , New York , NY , USA.
³ c Department of Biostatistics and Epidemiology , Memorial Sloan Kettering Cancer Center , New York , NY , USA.
⁴ d Department of Medicine, Adult Bone Marrow Transplant Service , Memorial Sloan Kettering Cancer Center , New York , NY , USA.
⁵ e Olink Proteomics , Uppsala , Sweden.
⁶ f Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center , New York , NY , USA.

No abstract available

Publication types